Publications

2018

Tabbo F, Nottegar A, Guerrera F, Migliore E, Luchini C, Maletta F, et al. Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma. Hum Pathol. 2018;75:167-178.
Gafeer MM, Mohammed KH, Ormenisan-Gherasim C, Choudhary F, Siddiqui MT, Cohen C. Diagnostic Utility of PD-L1 Expression in Lung Adenocarcinoma: Immunohistochemistry and RNA In Situ Hybridization. Appl Immunohistochem Mol Morphol. 2018;26(8):e86-e90.
Baker TM, Rogers W, Chavda KD, Westblade LF, Jenkins SG, Nicolau DP, et al. Epidemiology of Bloodstream Infections Caused by and That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible. Open Forum Infect Dis. 2018;5(12):ofy300.
Truong TH, Hu H, Temiz NA, Hagen KM, Girard BJ, Brady NJ, et al. Cancer Stem Cell Phenotypes in ER Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes. Mol Cancer Res. 2018;16(4):707-719.
de Brot S, Robinson BD, Scase T, Grau-Roma L, Wilkinson E, Boorjian SA, et al. The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology. Oncol Lett. 2018;16(2):1641-1649.
DeSimone RA, Sachais BS. Conservation of O- red blood cells: a fresh look at a shared responsibility. Transfusion. 2018;58(6):1333-1334.
DeSimone RA, Nowak MD, Lo DT, Crowley KM, Parra P, Cushing MM, et al. Logistical and safety implications of temperature-based acceptance of returned red blood cell units. Transfusion. 2018;58(6):1500-1505.
Goel R, Chappidi MR, Patel EU, Ness PM, Cushing MM, Frank SM, et al. Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014. JAMA. 2018;319(8):825-827.
Ooki A, Pena MD, Marchionni L, Dinalankara W, Begum A, Hahn NM, et al. YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells. Cancer Res. 2018;78(1):168-181.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700